Evidence-Based Supplement Reviews

Potent antioxidant that improves glucose uptake and reduces oxidative stress in peripheral nerves. Alpha-lipoic acid (ALA) has the strongest evidence for diabetic neuropathy symptom relief, with consistent results across multiple large clinical trials. It also shows modest benefits for insulin sensitivity and glucose control. The evidence is strongest for the 600mg/day dose administered intravenously, but oral supplementation at 600-1800mg/day also shows benefits.

Berberine is the single most studied natural compound for blood glucose management, with a level of evidence that approaches some prescription medications. Meta-analysis of 28 randomized controlled trials shows consistent A1C reduction of 0.5-0.9% and improvements in fasting and post-meal glucose. However, it has significant drug interactions, particularly with metformin, and should only be used under medical supervision.

Omega-3 fatty acids (EPA and DHA) have strong evidence for cardiovascular benefits in people with diabetes, who have 2-4x higher heart disease risk. While effects on glucose control are modest, the cardiovascular benefits are well-established. High-dose omega-3s (2-4g/day) significantly reduce triglycerides, a common issue in diabetes.

Psyllium husk fiber has strong evidence for reducing post-meal glucose spikes and improving overall glycemic control. Meta-analyses show consistent A1C reductions of 0.3-0.5% and significant improvements in fasting glucose. As a soluble fiber, it slows carbohydrate absorption and has additional benefits for cholesterol reduction.

Chromium is an essential trace mineral involved in insulin signaling. Clinical evidence shows modest benefits for glucose control, particularly in people with chromium deficiency (common in those with poor diet or high sugar intake). Results are inconsistent across studies, with better outcomes seen in Asian populations and those with poorer baseline control.

Magnesium deficiency is extremely common in diabetes (25-38% of patients) and is associated with worse glycemic control and higher complication risk. Supplementation shows modest improvements in fasting glucose and insulin sensitivity, with stronger effects in those who are deficient. Magnesium glycinate is preferred for its high absorption and minimal GI side effects.

Vitamin D deficiency is significantly more common in people with diabetes (60-90% depending on population) and is associated with worse glycemic control and higher complication risk. Supplementation shows modest benefits for insulin sensitivity and glucose control, particularly in those with documented deficiency. Testing vitamin D levels before supplementation is recommended.

Cinnamon has shown modest glucose-lowering effects in some studies, but results are inconsistent. Meta-analyses show small reductions in fasting glucose (10-25 mg/dL) with minimal impact on A1C. Ceylon cinnamon is preferred over Cassia cinnamon due to lower coumarin content, which can be toxic to the liver at high doses. Overall evidence is weaker than other supplements in our database.